The major pathological consequences of infection with the filarial parasite Wuchereria bancrofti are hydrocele, lymphedema, and, at the disease's most extreme stage, elephantiasis [1] . The development of filarial pathology is thought to be a multifaceted process in which extrinsic factors (high numbers of parasites in the body, transmission of a large number of larvae, and secondary bacterial infections) and intrinsic factors (host immune responses) play important roles [2, 3] . Data supporting the role for host T cells and host B cells in the pathogenesis of filarial disease come from both animal models and clinical studies of humans. Infection of either C3H/HeN nude mice [4] or BALB/c SCID mice [5] 
The major pathological consequences of infection with the filarial parasite Wuchereria bancrofti are hydrocele, lymphedema, and, at the disease's most extreme stage, elephantiasis [1] . The development of filarial pathology is thought to be a multifaceted process in which extrinsic factors (high numbers of parasites in the body, transmission of a large number of larvae, and secondary bacterial infections) and intrinsic factors (host immune responses) play important roles [2, 3] . Data supporting the role for host T cells and host B cells in the pathogenesis of filarial disease come from both animal models and clinical studies of humans. Infection of either C3H/HeN nude mice [4] or BALB/c SCID mice [5] with Brugia malayi parasites-which are phylogenetically similar to W. bancrofti parasites-resulted in lymphatic dilatation and lymphangitis but not in lymphatic obstruction. Only after these mice were given donor T cells and B cells did they develop obstructive pathology that included massive lymph thrombi and interstitial infiltrates [5, 6] . In human filarial disease (lymphedema), examination of inflammatory responses in local tissues reveals an abnormal T cell infiltrate, expression of the cell-surface markers HLA-DR and vascular cell adhesion molecule 1, and T cells with a bias for specific antigens [7, 8] .
Recruitment of T cells and B cells to the site of infection, therefore, represents an important step in the pathogenesis of lymphedema. By promoting both chemotaxis and activation of integrins, chemokine receptors control these homing events of T cells and of B cells; thus, the expression of chemokine receptors defines distinct trophic and functional properties for T cells and for B cells [9] . Indeed, altered expression of NOTE. Data are median (range) percentage of cells that showed staining. Peripheral-blood lymphocytes from filaria-infected individuals with chronic pathology/lymphedema (CP), chronically infected but asymptomatic individuals (CA+), and uninfected individuals (UN) were stained for lineage markers-CD3, CD56, and CD19-as well as for a variety of activation/phenotypic markers and were analyzed by flow cytometry. There were no significant differences between the 3 groups.
chemokine receptors is associated with the development of disease in some parasitic infections, such as schistosomiasis [10] and Chagas disease [11] . In addition, chemokine receptors have been implicated in the pathogenesis of rheumatoid arthritis, multiple sclerosis, atopic dermatitis, Crohn disease, and allergic asthma [12] .
Therefore, we examined the expression of chemokine receptors (both CCR and CXCR) on the surface of T cells and on B cells in filaria-infected individuals with chronic pathology/ lymphedema (CP) and compared this expression to that seen in chronically infected but asymptomatic individuals (CA+) and to that seen in uninfected individuals (UN). Our data suggest that CCR9-expressing T cells and CCR9-expressing B cells play a role in the mediation of the lymphatic pathology associated with filarial infections.
SUBJECTS, MATERIALS, AND METHODS

Study population.
We studied a cohort of 27 individuals in Tamil Nadu, in southern India, where lymphatic filariasis is endemic (table 1) . This cohort comprised 9 CP individuals, 9 CA+ individuals, and 9 UN individuals. The status of active infection was determined by the ICT filarial antigen test (Binax), by the Trop Bio Og4C3 ELISA (TropBio), and by clinical evaluation of pathology. Each UN individual was negative for filarial antigens and had no evidence of lymphedema. Each CA+ individual was positive for filarial antigens and had no clinical evidence of lymphatic pathology. The illness of each CP individual was classified according to the standard 4 grades that have been established by the World Health Organization (WHO) [13] : grade 1, pitting edema that is reversible by elevation of the affected limb; grade 2, pitting/nonpitting edema that is not reversible by elevation of the affected limb; grade 3, nonpitting edema that is not reversible by elevation of the affected limb and that is accompanied by thickening of the skin; grade 4, nonpitting edema of the limb that is accompanied by fibrotic and verrucous skin changes (elephantiasis). Informed consent was obtained from patients who participated in the present study, and the human-experimentation guidelines of the US Department of Health and Human Services were followed in the conduct of clinical research.
Isolation of peripheral-blood lymphocytes. Samples of heparinized blood were collected, and peripheral-blood lymphocytes (PBLs) were isolated by Ficoll-diatrizoate gradient centrifugation (LSM; ICN Biomedicals). Erythrocytes were lysed by use of ACK lysis buffer (Biosource). Cells were then washed and cryopreserved in a medium containing RPMI-1640 (BioWhittaker), 10% heat-inactivated fetal calf serum (Harlan Bioproducts for Science), and 20% dimethyl sulfoxide (Fisher Scientific). Also, additional serum samples were collected and frozen for further analysis. Preparation of parasites. Live, infective-stage larvae (L3) and live microfilariae (Mf) of B. malayi were provided by Dr. John McCall (University of Georgia, Athens) and were repeatedly washed in RPMI-1640 with antibiotics and were cultured in 5% CO 2 at 37ЊC.
In vitro culture. PBLs were cultured, with either L3 (5-10/ well) or Mf (50,000 /well), in 24-well tissue-culture plates (Corning), at a concentration of cells/well; 24 h later, 6 5 ϫ 10 cells were washed in a buffer of PBS and 0.1% bovine serum albumin and were stained for flow cytometry.
Reagents for flow cytometry. Antibodies used for phenotype analysis were from BD Pharmingen/BD Biosciences, and antibodies used for analysis of chemokine receptors were from R&D Systems. The following antihuman antibodies were used: CD69, CD71, CD45RA, CD138, and CD56, labeled with fluorescein isothiocyanate; CD25, CD27, CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, and CCR9, labeled with phycoerythrin; were used: CD45RO and CD19, labeled with peridinin chlorophyll protein; and CD3, labeled with allophycocyanin.
Flow cytometry. Cryopreserved PBLs were thawed, were washed in a buffer of PBS and 0.1% bovine serum albumin, and were stained for the presence of various surface markers and chemokine receptors. Fluorescence was measured on a FACSCaliber (Becton Dickinson) by use of 10,000 gated lymphocytes.
ELISA. In serum from 5 individuals in each group, levels of interleukin (IL)-8, RANTES, macrophage inflammatory protein (MIP)-1a, MIP-1b, growth-related oncogene a (GROa), monocyte chemotactic protein (MCP)-1, thymus-and-activation-regulated chemokine (TARC), and interferon-inducible protein (IP)-10 chemokines were measured by use of Searchlight Multiplex ELISA Technology (Pierce Biotechnology).
Statistical analysis. The data were compared by use of either the Mann-Whitney test, the Wilcoxon signed-rank test, or Spearman rank correlation. All statistics were derived by use of StatView 5 software (SAS Institute).
RESULTS
Absence of intergroup differences in the numbers of T cells and B cells.
To assess the impact that the numbers of T cells and B cells had on clinical filarial disease, the relative proportions of T cells (CD3 + /CD56 Ϫ ) and B cells (CD19 + ) in peripheral blood from individuals in the CP, CA+, and UN groups were analyzed; no significant differences were found between the groups (table 2). T cells from individuals in the 3 groups were examined for surface expression of CD69, CD25, and CD71 (all activation markers), CD45RA (a marker of naive T cells), and CD45RO (a marker of effector/memory T cells); no significant differences were detected between the 3 groups ( Regulation of expression of chemokine receptors, in response to L3. To assess the regulation of chemokine receptors by filarial parasites, PBLs from CP individuals ( ) were stimn p 5 ulated with either L3 or Mf of B. malayi for 24 h, and the expression of chemokine receptors CXCR1, CXCR3, and CCR9 was examined. No significant differences were observed in the percentages of either T cells and B cells that expressed CXCR1 and CXCR3 or in the mean fluorescent intensity (density of expression) of the receptors in response to either L3 or Mf, compared with those of unstimulated controls (data not shown); however, both (1) the percentages of CCR9-expressing T cells (data not shown) and CCR9-expressing B cells ( , by P p .0431 Wilcoxon signed-rank test) and (2) the mean fluorescent intensity of CCR9 receptors ( , by Wilcoxon signed-rank P p .0431 test) in response to L3 but not in response to Mf were higher than those of unstimulated controls ( figure 3A and B) . We also examined the regulation, in response to L3 and Mf in vitro, of CXCR1, CXCR3, and CCR9 in UN individuals and in CA+ individuals; we found no significant differences from the results seen in unstimulated controls (data not shown).
Expression of CCR9 is possibly associated with the grade of lymphedema seen in CP individuals. To investigate the possible involvement of CCR9 in the development of lymphedema, we examined the correlation between the grade of lymphedema in CP individuals and the percentages of both T cells and B cells that expressed chemokine receptors. The grade of lymphedema, based on the WHO classification system, was significantly correlated with the percentages of both CCR9-expressing T cells ( , by Spearman correlation) and CCR9-expressing B cells P p .03 ( , by Spearman correlation) (figure 4). P p .017
Levels of chemokines in serum are significantly higher in CP individuals than in UN individuals. To assess the role that chemokines (CCR and CXCR ligands) play in the pathogenesis of filarial disease, the levels of selected chemokines in serum were measured in a subset ( ) of individuals in each n p 5 group. The levels of IL-8 ( , by Mann-Whitney test), P p .009 MIP-1a (
, by Mann-Whitney test), MIP-1b (P p .009, P p .047 by Mann-Whitney test), MCP-1 ( , by Mann-Whitney P p .009 test), TARC ( , by Mann-Whitney test), and IP-10 P p .028 ( , by Mann-Whitney test) were significantly higher in P p .009 CP individuals than in UN individuals (figure 5). No intergroup differences in the levels of either RANTES or GROa were observed. It is of interest is that, for all the chemokines examined, the levels in serum were not significantly different in CP individuals compared with CA+ individuals.
DISCUSSION
In areas in which lymphatic filariasis-an infectious disease with a spectrum of clinical manifestations-is endemic, individuals most commonly fall into the 3 categories: infected subjects free of overt clinical disease (whom the present article has denoted "CA+"); patients with chronic disease manifestations with or without active infection (whom the present article has denoted as "CP"); and individuals free of both infection and disease (whom the present article has denoted as "UN") [1] . The most debilitating consequences of filarial infection are lymphedema and elephantiasis, which have significant economic and psychosocial effects on both the infected individual and the community [14] . Indeed, the global burden of lymphatic filariasis has been estimated as a loss of 5.549 million disabilityadjusted life-years (a loss exceeded only by that for malaria and that for tuberculosis) [14] . The lymphatic damage in filariasis is thought to evolve as a consequence of either mechanical damage or dysfunction associated with live parasites, bacteriainduced chronic inflammation, and host immune responses [3] . To gain insight into the pathogenesis of lymphedema, we examined the expression of chemokine receptors by cells likely to infiltrate the site of pathology.
We first estimated quantitative and qualitative differences in T cells and B cells from CP individuals, from CA+ individuals, and from UN individuals. We found no intergroup differences in the relative proportions of T cells and B cells or the expression of either activation or phenotypic markers. Our analysis included study of T cell-activation markers (CD69, CD25, and CD71) and T cell-naive and effector/memory markers (CD45RA/CD45RO). We also found no intergroup differences in the proportions of naive B cells, memory B cells, and plasma cells in the peripheral blood. These results suggest that the intergroup differences in clinical manifestations cannot be attributed to obvious differences in either the numbers/percentages or the activation/differentiation states of T cells and of B cells. We then examined the expression of CXC and CC chemokine receptors on the surface of T cells and of B cells. We found significantly lower percentages of both T cells and B cells that expressed CXCR1 and CXCR3 and significantly higher percentages of both T cells and B cells that expressed CCR9 in CP individuals, compared with those in CA+ and UN individuals. CXCR1 and CXCR3 are important receptors for recruitment of Th1 cells, and CCR9 is a marker of gut-homing lymphocytes [15, 16] . The only known ligand for CCR9, thymus-expressed chemokine (TECK), is a tissue-specific chemokine expressed predominantly in the epithelium of the small intestine and on endothelial surfaces [17] . We hypothesize that expression of TECK on lymphatic endothelium directs CCR9-expressing T cells and CCR9-expressing B cells to the site of lymphatic pa-thology. In further confirmation of our hypothesis, we found, in the 9 CP individuals, a significant correlation between the grade of lymphedema and the percentages of CCR9-expressing T cells and CCR9-expressing B cells.
We next examined the regulation, in response to L3 and Mf, of CXCR1, CXCR3, and CCR9. We observed that, in T cells and B cells of CP individuals, CCR9 is significantly up-regulated in response to L3 but is not up-regulated in response to Mf. This observation suggests that the trigger for the development of lymphatic damage in individuals predisposed to lymphatic pathology might be the increase, in response to incoming larvae, of CCR9-expressing T cells and CCR9-expressing B cells. Analyses of the regulation of CCR9 in CA+ individuals and in UN individuals revealed no changes in response to either L3 or Mf, indicating that up-regulation of CCR9 is a unique property of CP individuals. Neutralizing antibodies or small-molecule antagonists are being used to inhibit chemokine receptors in experimental treatments of a variety of disorders-for example, CCR3 for asthma [18] , CCR1 for experimental allergic encephalitis [19] , CXCR3 for cardiac allograft rejection [20] , and CCR5 for HIV infection [21] . Thus, it is conceivable that CCR9, used as an antagonist, would present a potent weapon for the prevention of lymphedema in areas where filariasis is endemic.
An unrelated but interesting observation in our studies was the lower percentage of CXCR4-expressing T cells in CA+ individuals, compared with that in CP individuals and that in UN individuals. Because CXCR4 is a coreceptor for T-trophic HIV [22] , this expression pattern might render CP individuals and CA+ individuals less susceptible to HIV infection than UN individuals are, although data from a different cohort of filariainfected patients suggest otherwise [23] . Finally, we examined the levels of different chemokines in serum from a subset of our 3 groups. The levels of IL-8, MIP-1a, MIP-1b, MCP-1, TARC, and IP-10 were significantly higher in CP individuals than in UN individuals It is noteworthy that IL-8 is a ligand for CXCR1, IP-10 is a ligand for CXCR3, and TARC is a ligand for CCR4, and all of these chemokine receptors are expressed at significantly different levels in CP individuals, compared with those in UN individuals. Hence, a chemokine/chemokine-receptor network that involves these receptor-ligand pairs might be operational in the disease process of filariasis.
In conclusion, our results suggest that, in CP individuals, there is an augmented expression of CCR9 and a diminished expression of both CXCR1 and CXCR3, compared with those in CA+ individuals and those in UN individuals. Our results also reveal a significant correlation between the expression of CCR9 and the grade of lymphedema in CP individuals. Finally, the expression of CCR9 in response to L3 is significantly higher in CP individuals, compared with that in unstimulated controls. Together, these data highlight the possible participation of the chemokine network in the pathogenesis of lymphedema and could provide us with tools to manipulate the immune system to prevent debilitating pathology.
